|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$110
|
$297B |
4.6x |
10.0x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$196B |
3.2x |
7.9x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$44
|
$13.4B |
7.0x |
-4.2x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$114
|
$11.5B |
3.7x |
-9.3x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$6.4B |
58.0x |
N/A |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$54
|
$5.4B |
N/A |
-6.4x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$2.4B |
314.6x |
-11.6x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$21
|
$1.9B |
7.6x |
-5.2x |
|
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$21
|
$1.7B |
N/A |
N/A |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$15
|
$1.4B |
4.1x |
57.0x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$31
|
$1.3B |
491.1x |
-8.5x |
|
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$47
|
$1.1B |
5.3x |
-39.9x |
|
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$1.1B |
405.0x |
-4.1x |
|
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$927M |
N/A |
-12.0x |
|
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$9
|
$926M |
0.9x |
2.4x |
|
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$828M |
10.0x |
-76.2x |
|
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$784M |
16.7x |
-4.0x |
|
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$630M |
30.3x |
-1.3x |
|
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$37
|
$581M |
13.5x |
-3.9x |
|
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$521M |
N/A |
N/A |
|
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$475M |
84.8x |
N/A |
|
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$30
|
$413M |
N/A |
N/A |
|
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$408M |
8.1x |
-7.3x |
|
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$311M |
N/A |
-1.8x |
|
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$303M |
241.1x |
-1.0x |
|
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$294M |
N/A |
-11.4x |
|
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$240M |
N/A |
-5.2x |
|
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$238M |
131143.9x |
-1.2x |
|
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$235M |
10422.9x |
-1.3x |
|
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$223M |
N/A |
N/A |
|
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$185M |
5.6x |
N/A |
|
Shattuck Labs
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$162M |
135.0x |
-3.4x |
|
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$145M |
1.1x |
N/A |
|
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$127M |
N/A |
N/A |
|
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$113M |
N/A |
-0.6x |
|
Coherus Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$110M |
2.5x |
-0.6x |
|
SAB Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$103M |
N/A |
N/A |
|
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$1
|
$102M |
N/A |
N/A |
|
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$101M |
N/A |
N/A |
|
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$97.6M |
N/A |
-3.9x |
|
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$86.5M |
N/A |
N/A |
|
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$82.5M |
N/A |
N/A |
|
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$75.8M |
N/A |
N/A |
|
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$74.1M |
14.8x |
N/A |
|
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$70.5M |
798.3x |
N/A |
|
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$69.6M |
11.8x |
N/A |
|
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$1
|
$63.0M |
0.8x |
-0.2x |
|
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$53.1M |
N/A |
N/A |
|
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$46.7M |
N/A |
N/A |
|
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$46.0M |
23.4x |
N/A |
|
ALX Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$43.8M |
N/A |
N/A |
|
Atara Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$41.1M |
0.3x |
1.1x |
|
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$40.7M |
N/A |
N/A |
|
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$37.3M |
N/A |
-1.1x |
|
Tonix Pharmaceuticals
|
United States of America |
Vaccines & Immunotherapies
|
$17
|
$30.8M |
2.9x |
N/A |
|
TuHURA Biosciences
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$28.6M |
N/A |
N/A |
|
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$18.0M |
2.5x |
N/A |
|
Liminatus Pharma
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$15.8M |
N/A |
N/A |
|
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$15.6M |
234.2x |
N/A |
|
Intensity Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$15.3M |
N/A |
N/A |
|
NextCure
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$11
|
$13.3M |
N/A |
N/A |
|
HCW Biologics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$9.4M |
348.8x |
N/A |
|
Marker Therapeutics
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$2
|
$9.3M |
3.0x |
-0.6x |
|
IO Biotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$8.3M |
N/A |
-0.1x |
|
Macrogenics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$6.4M |
0.1x |
N/A |
|
Werewolf Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$3.7M |
N/A |
-0.1x |
|
Geovax Labs
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$3
|
$3.4M |
1.4x |
N/A |
|
Bolt Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$3.0M |
0.5x |
N/A |
|
Fate Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$0.1M |
-0.0x |
0.0x |
|
Adicet Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
-$10.9M |
-3.8x |
N/A |
|
Artiva Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
-$15.8M |
N/A |
N/A |
|
TScan Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$30.9M |
-2.9x |
0.2x |
|
Barinthus Biotherapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$33.3M |
N/A |
N/A |
|
Nkarta
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
-$48.7M |
N/A |
N/A |
|
Xilio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
-$56.3M |
N/A |
N/A |
|
XBiotech
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
-$85.9M |
N/A |
N/A |